检查痴呆症的异质性,使用基于数据的认知资料的无监督聚类
Sayantan Kumar1,2, Inez Y Oh2, Suzanne E Schindler3
1Department of Computer Science and Engineering, McKelvey School of Engineering, Washington University in St Louis, St. Louis, Missouri, United States of America.
PloS one
|November 14, 2024
概括
这项研究使用纵向数据的认知得分来确定不同的痴呆症亚型,揭示了早期疾病和进展风险的更大异质性. 这有助于我们了解阿尔茨海默病和昂贵的生物标志物之外的其他疾病.
科学领域:
- 神经学 神经学
- 老年学是指老年学的学科.
- 数据科学数据科学数据科学
背景情况:
- 痴呆症是一个异质的疾病,症状和进展率各不相同.
- 现有的痴呆症亚型研究往往只关注阿尔茨海默病,使用有限的基线数据,并依赖昂贵的成像生物标志物.
- 需要数据驱动的方法来理解整个认知衰退谱的痴呆症异质性.
研究的目的:
- 用数据驱动的,无监督的集群方法来识别不同的痴呆症亚型.
- 通过分析纵向认知数据,克服先前研究的局限性,避免依赖昂贵的成像.
- 探索已识别的痴呆症亚型与随着时间的推移疾病进展之间的关系.
主要方法:
- 采用数据驱动的无监督集群算法 (SillyPutty) 结合层次集群.
- 利用来自现实世界临床痴呆症队列的纵向认知评估得分.
- 分析了亚型和疾病进展之间的时间关系,超越了横截面数据.
主要成果:
- 在临床队列中确定了不同的痴呆症亚型.
- 非常轻度或轻度痴呆阶段的亚型在认知概况中表现出显著的异质性.
- 这些早期的亚型也显示出疾病进展的各种风险.
结论:
- 使用纵向认知数据进行数据驱动的亚型化可以揭示痴呆症的显著异质性,特别是在早期阶段.
- 与仅限于阿尔茨海默病或横截面数据的研究相比,这种方法提供了对痴呆症异质性的更全面的理解.
- 了解亚型特异性进展对于个性化痴呆症护理和未来研究至关重要.
更多相关视频
09:21Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
1.4K
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
960
相关概念视频
Dementia
97
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
97
Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
